Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
INSIGHT PROVIDER
Wilsons Advisory
External broker reports(aggregated public sources)
•
Wilsons Advisory
Message
Follow
Location:
Australia
Joined:
13 June 2022
42
Insights
12.0k
Views
4
Followers
Australia
•
Equity Bottom-Up
Message
Follow
Regions
Sectors
Verticals
More Filters
Refresh
Top Picks Only
Recent
bullish
•
Mach7 Technologies
•
03 Sep 2024 03:40
•
Broker
Mach7 Technologies (M7T) - FY24: Transformative
The VA Phase II contract remains as attractive upside in FY25, which given M7T’s execution to date, we expect is more likely theirs than not.
Wilsons Advisory
142 Views
Share
bullish
•
Mach7 Technologies
•
03 Sep 2024 03:37
•
Broker
Mach7 Technologies (M7T) - FY24: First Scan
Mach7 have released their FY24 result, noting TCV was pre-released at their 4Q24 update. Operating costs were well managed leading to a $1M EBTIDA...
Wilsons Advisory
138 Views
Share
bullish
•
Mach7 Technologies
•
12 Aug 2024 21:10
•
Broker
Mach7 Technologies (M7T) - 4Q24: First Look, Is Looking Good
Mach7 have released their 4Q24 update. They have won an additional $4.4M of TCV in 4Q24, bringing total sales order wins to $61.3M for FY24
Wilsons Advisory
128 Views
Share
bullish
•
Clarity Pharmaceuticals Ltd
•
17 May 2024 18:40
•
Broker
Clarity Pharmaceuticals (CU6) - O/W: Better Late than Fuzzy
Evaluation of Clarity’s opportunity with their 64Cu-SARbisPSMA PET/CT agent in prostate cancer drives our upgrade in part – recognising that they...
Wilsons Advisory
299 Views
Share
bullish
•
Mach7 Technologies
•
03 May 2024 18:32
•
Broker
Mach7 Technologies (M7T) - 3Q24: Better Visualisation
We maintain our OVERWEIGHT rating and $1.05/sh PT on Mach7. The release of Mach7’s 3Q24 trading update revealed the clear air that investors have...
Wilsons Advisory
326 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x